We are research-driven pharmaceutical company who develop,manufacture and supply differentiated generic products in the oral solid dosage forms,both as pre-formulation intermediates as well as finished formulation for certain key therapeutic segments. We offer both pharmaceutical and nutraceutical products.
We have in-house R&D capabilities to offer a range of non-infringing drug delivery solutions based on process technologies that bring patient compliance thereby reduces the cost of treatment.
We provide our customers with a comprehensive range of solutions that include product conceptualization,development,clinical studies,regulatory support for dossier development and submission,product registrations,manufacture and supplies.
Our offerings cover differentiated generic products as finished formulations and pre-formulations intermediates,which include granules,pellets (immediate,modified,delayed release, etc.), taste-masked powders,dry suspensions,tablets,capsules, and oral thin films.
ZIM Labs uses its proprietary knowledge, technology and manufacturing process expertise to bridge the technology gap in Pharmerging and ROW markets while assisting local players in various geographies to launch differentiated / combination generic products to compete in their respective local markets.